We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder

This study has been terminated.
(The investigator at Cedars stopped this study due to problems collecting payment from the sponsor.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00572377
First Posted: December 13, 2007
Last Update Posted: June 20, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Cedars-Sinai Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)